Baltimore, April 30, 2014 (GLOBE NEWSWIRE) -- vitaTrackr, Inc., the global leader in organizing an independent and agnostic health data market today announces MedCitti as a Spotlight Strategic Partner.
"Since launching the vitaTrackr Strategic Partner Program on April 8, vitaTrackr has heard from companies across all sectors. Some well-established, others early stage - all share a vision of a better, more efficient health system" said Brian Baum, founder and CEO of vitaTrackr. "Data" of itself is of limited value; where things get interesting is when the participants of the vitaTrackr marketplace engage and add value to it. It is there that the future of healthcare lies. Given the diversity of companies joining the Partner Program, vitaTrackr will periodically showcase the businesses of our partners.
MedCitti is an exciting early stage company that has a talented team, incredible research and patent-pending technology. MedCitti's methodology applies evidence based regression analysis to analyze and estimate future lifetime treatment costs and out-of-pocket expenses for diseases related to obesity. Reports can be processed at a population level and down to the individual (age 18 and above). An android based application can be used by individual consumers to understand the impact of their health decisions, the future costs of those decisions and actions they can take to modify outcomes and costs. The app also updates cost projections based on changes in body mass index and risk factors. Consumers can use the information provided to monitor their health, adopt health improvement strategies to improve health and mitigate costs.
Dr. Neela Srinivas, founder and Chief Data Scientist of MedCitti said "our application at the consumer level currently utilizes age and BMI as variables for analysis. With these variables, the accuracy of our application for general forecasts is significantly high. The vitaTrackr marketplace provides the opportunity to obtain additional consumer authorized data such as blood pressure, cholesterol, blood sugar and many other metrics. The accuracy of our application will increase exponentially for personalized forecasts."
Dr. Sri Halthore, Chief Medical Officer of MedCitti, stated that "the objective of MedCitti is to empower people to help themselves improve their health and the quality of their life. Applied data is the foundation."
"vitaTrackr is exciting, but watching organizations join a neutral health data marketplace, innovate new solutions and improve care - that is the future of healthcare", said Baum.
If your company is interested in ushering in the era of data-enabled healthcare, join the vitaTrackr Strategic Partner Program. Download a registration kit at http://www.vitatrackr.com/partner-program.html
vitaTrackr is a health data marketplace facilitating the movement of health data from point of creation to qualified destinations that value it. The vitaTrackr marketplace is an industry-wide utility benefiting all, but advantaging no individual sector or entity. The consumer, (data owner) authorizes data transfers.
Join the discussion www.healthdataneutrality.com
MedCitti bends the cost curve in healthcare with outcomes focused preventive strategies powered by data analytics. Its patent pending methodology leverages historic member data, medical evidence and statistical regression models to estimate future risk factors, treatment costs, out-of-pocket expenses and direct payments by insurance companies. The MedCitti software-as-a-service platform supports organizational health management and extends its application to individuals via an android based application to manage health risks and costs.
CONTACT: vitaTrackr, Inc. MedCitti Brian Baum Dr. Neela Srinivas CEO, vitaTrackr, Inc. Founder, Chief Data Scientist 410.489.2841 732.893.0951 brian.baum@vitaTrackr.com email@example.com www.vitaTrackr.com www.medcitti.com
Source: vitaTrackr, Inc.